REAL-WORLD PRESCRIBING PATTERNS IN US MULTIPLE MYELOMA (MM) PATIENTS REFRACTORY TO LENALIDOMIDE IN THE FRONT-LINE

被引：0
|
作者：
Jhaveri, M. [1 ]
Romanus, D. [1 ]
Raju, A. [2 ]
Seal, B. [1 ]
Farrelly, E. [2 ]
Yong, C. [1 ]
Noga, S. [3 ]
Labotka, R. [4 ]
Blazer, M. [5 ]
Parameswaran, H. [6 ]
机构：
[1] Millennium Pharmaceut Inc, Global Outcomes Res, Cambridge, MA USA
[2] Xcenda, Real World Evidence, Palm Harbor, FL USA
[3] US Med Affairs, Cambridge, MA USA
[4] Millennium Pharmaceut Inc, Oncol Clin Res, Cambridge, MA USA
[5] Xcenda, Global Hlth Econ & Outcomes Res, Palm Harbor, FL USA
[6] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1312
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [2] REAL-WORLD CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN US PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
    Nicacio, L. Viana
    Calkins, G.
    Curtis, M.
    Kohansimeh, J.
    Lindberg, F. P.
    Larrabee, K.
    Jaskiw, A.
    Feinstein, R. N.
    Terry, M.
    Plotkin, L.
    Palladino, M. L.
    Krishna, A.
    Green, R. J.
    [J]. HAEMATOLOGICA, 2015, 100 : 742 - 742
  • [3] Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    [J]. FUTURE ONCOLOGY, 2015, 11 (11) : 1643 - 1658
  • [4] Bortezomib and lenalidomide as front-line therapy for multiple myeloma
    Zou, Yandun
    Lin, Mingzhen
    Sheng, Zhixin
    Niu, Shaona
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2024 - 2031
  • [5] Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    [J]. EJHAEM, 2023, 4 (04): : 984 - 994
  • [6] Real-World Multiple Myeloma Front-Line Treatment and Outcomes By Transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    [J]. BLOOD, 2022, 140 : 7187 - 7188
  • [7] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [8] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    [J]. HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [9] Patient characteristics and burden in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Gay, Francesca
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Martinez-Lopez, Joaquin
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S295
  • [10] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
12345